Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Connecticut for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Connecticut only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Connecticut (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Matthew Dombrow (NPI 1376798967)

Field	Value
Entity Type	Individual
Organization	Matthew Dombrow
Address	2440 Whitney Ave
City	Hamden
State	CT
ZIP	06518
Taxonomy	Ophthalmology Physician
NPI Enumerated	November 24, 2008

Payer Source	Total Paid
Medicare	$1M
Medicaid	$0

Key Findings

This provider’s Medicare activity is the clear revenue base: total Medicare revenue is $1M while there is no Medicaid billing on file, making the practice effectively single-payer (Medicare) in the available claims data. The lack of Medicaid billing suggests limited exposure to state payer volumes and reimbursement mixes.

Revenue is highly concentrated in three Medicare codes: the precomputed top-3 Medicare codes account for 92.0% of this provider’s total Medicare revenue, with J0178 driving $446.3K (44.1%) and J2777 driving $421.1K (41.6%), while 67028 contributes $64.2K (6.3%). This concentration indicates that a very large share of income comes from a small number of procedure/drug codes.

The code mix indicates a retina-focused, procedure-driven ophthalmology practice: J0178 (aflibercept) and J2777 (faricimab) are the two largest revenue sources and 67028 represents intravitreal injections as a billed procedure. In addition, 92134 (retinal imaging) appears in the top codes, so the operation centers on intravitreal anti-VEGF therapies and associated retinal diagnostics rather than high-volume evaluation-and-management encounters.

Competitive standing on the top injection and retina codes is modest rather than dominant nationally: J0178 ranks #1717 of 3204 providers nationally (46th percentile; typical, unremarkable volume for this code), J2777 ranks #735 of 2039 (64th percentile; typical, unremarkable volume for this code), and 67028 ranks #1907 of 4255 (55th percentile; typical, unremarkable volume for this code). Notably, 92134 ranks #2231 of 26868 providers nationally (92th percentile; typical, unremarkable volume for this code), indicating relatively higher standing on retinal imaging compared with peers.

Practice tenure is long-standing: the NPI was enumerated on 2008-11-24 (~18 years ago), indicating an established provider with nearly two decades of Medicare participation that may support ongoing referral relationships and operational stability. This longevity aligns with the concentrated, procedure-heavy billing profile expected from an established retinal specialist.

The non-injection E/M and comprehensive visit codes contribute only small shares of Medicare revenue (92012: 201 claims, $14.3K revenue, 1.4%; 92014: 146 claims, $13.9K revenue, 1.4%; 99204: 81 claims, $10.4K revenue, 1.0%), reinforcing that visits are not the primary revenue driver. These figures show the practice earns most dollars from drug-injection and procedure codes rather than routine office visit billing.

Smaller therapy and procedure codes further illustrate the clinical mix: J9035 (bevacizumab) accounts for $11.5K (1.1%) on 209 claims while 92250 (fundus photos) is minimal at $608 (0.1%) on 19 claims. Compared with the large revenues from J0178 and J2777, the pattern suggests Medicare billing that favors aflibercept and faricimab use over bevacizumab in the captured claims.

The absence of Medicaid billing combined with concentrated Medicare revenue creates operational implications for payer negotiations and network strategy: the provider’s reimbursement exposure is concentrated in Medicare-covered anti-VEGF injections and related procedures, which may simplify but also concentrate reimbursement risk if payer policies or utilization patterns change. Analysts should treat this entity as a specialized, Medicare-centered injection practice rather than a broad ambulatory ophthalmology clinic.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

9 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	640	$690	$446.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	14,520	$30	$421.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	640	$100	$64.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	960	$30	$30.8K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	200	$70	$14.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	150	$100	$13.9K
J9035	Injection, bevacizumab, 10 mg	210	$60	$11.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	80	$130	$10.4K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	20	$30	$610

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Connecticut Distribution

Matthew Dombrow — 0 of 9 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Connecticut

Full comparison — all codes billed, vs. state median

9 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	27	40	830	$690	$713.1K
J2777	8	30	8,190	$30	$340.4K
67028	25	50	540	$100	$66.4K
92014	218	580	100	$90	$18.6K
92012	100	300	120	$70	$15.2K
J9035	13	30	130	$50	$10.4K
92134	29	320	60	$30	$7.7K
99204	221	2,660	30	$120	$4.6K
92250	365	430	60	$30	$3.1K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Matthew Dombrow, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Connecticut Retina Consultants LLC	CT	Ophthalmology Physician	$0	$8.3M
Wayne Larrison	CT	Ophthalmology Physician	$1.9M	$0
Nancy Miller-rivero	NY	Retina Specialist (Ophthalmology) Physician	$1.4M	$0
James Weisz	CT	Ophthalmology Physician	$1.3M	$0
Meredith Gershon	CT	Ophthalmology Physician	$834.7K	$0
Richard Kaplan	CT	Ophthalmology Physician	$800.1K	$0
Aaron Steen	CT	Dermatology Physician	$364.3K	$0
Andrew Herbst	CT	MOHS-Micrographic Surgery Physician	$333.9K	$0
Jason Mayo	CT	Diagnostic Radiology Physician	$267.4K	$0
Christopher Lynch	CT	Adult Reconstructive Orthopaedic Surgery Physician	$264K	$0

Nearby Providers

Other providers in the same ZIP code as Matthew Dombrow, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Patient Care Hha, LLC	CT	Home Health Agency	$0	$14.6M
Home Health Professionals Network	CT	Home Health Agency	$0	$9.8M
New England Retina Associates, P.C	CT	Retina Specialist (Ophthalmology) Physician	$0	$4.4M
The Center For Pediatric And Family Growth	CT	Behavior Analyst	$0	$3.4M
Heartcare Associates Of Connecticut, LLC	CT	Cardiovascular Disease Physician	$0	$3M
Children's Medical Group, LLC	CT	Pediatrics Physician	$0	$2.6M
Hamden Sleep Disorders Center LLC	CT	Sleep Medicine (Internal Medicine) Physician	$177K	$2.3M
David Tom	CT	Ophthalmology Physician	$2.5M	$0
Drs Chen And Seignemartin LLC	CT	Pediatric Dentistry	$0	$2.1M
Hamden Medical Group, LLC	CT	Family Medicine Physician	$0	$1.5M

Matthew Dombrow — Billing Profile & Reimbursement Data

Sign up for Matthew Dombrow — Billing Profile & Reimbursement Data policy alerts

Matthew Dombrow — Billing Profile & Reimbursement Data

Sign up for Matthew Dombrow — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References